Susan Thaul and Dana Hotra, Editors; Committee to Review the NIH Women's Health Initiative, Institute of Medicine

Select Guide Rating

• 1 Front Matter; 2 Executive Summary; 3 Introduction; 4 Clinical Trial; 5 Observational Study; 6 Community Prevention Study; 7 Concluding Remarks; 8 References; 9 Appendix A: Clinical Trial Exclusion Criteria; 10 Appendix B: U.S. House of Representatives Appropriations COmmittee; 11 Appendix C: Statement of Task; 12 Appendix D: Documents Received by the Institute of Medicine from the National Institutes of Health; 13 Appendix E: Meeting Participants June, July, and August 1993; 14 Appendix F: Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial; 15 Appendix G: Women's Health Initiative Committees; 16 Appendix H: NIH-Sponsored Women's Health Studies; 17 Appendix I: NIH Cost and FTE Summary for Vanguard Clinical Centers; 18 Appendix J: NIH Power Calculations; 19 Appendix K: Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators; 20 Appendix L: Abbreviations and Acronyms; 21 Appendix M: Committee and Staff Biographies

Susan Thaul and Dana Hotra, Editors; Committee to Review the NIH Women's Health Initiative, Institute of Medicine

Select Guide Rating

• 1 Front Matter; 2 Executive Summary; 3 Introduction; 4 Clinical Trial; 5 Observational Study; 6 Community Prevention Study; 7 Concluding Remarks; 8 References; 9 Appendix A: Clinical Trial Exclusion Criteria; 10 Appendix B: U.S. House of Representatives Appropriations COmmittee; 11 Appendix C: Statement of Task; 12 Appendix D: Documents Received by the Institute of Medicine from the National Institutes of Health; 13 Appendix E: Meeting Participants June, July, and August 1993; 14 Appendix F: Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial; 15 Appendix G: Women's Health Initiative Committees; 16 Appendix H: NIH-Sponsored Women's Health Studies; 17 Appendix I: NIH Cost and FTE Summary for Vanguard Clinical Centers; 18 Appendix J: NIH Power Calculations; 19 Appendix K: Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators; 20 Appendix L: Abbreviations and Acronyms; 21 Appendix M: Committee and Staff Biographies

Susan Thaul and Dana Hotra, Editors; Committee to Review the NIH Women's Health Initiative, Institute of Medicine

Select Guide Rating

• 1 Front Matter; 2 Executive Summary; 3 Introduction; 4 Clinical Trial; 5 Observational Study; 6 Community Prevention Study; 7 Concluding Remarks; 8 References; 9 Appendix A: Clinical Trial Exclusion Criteria; 10 Appendix B: U.S. House of Representatives Appropriations COmmittee; 11 Appendix C: Statement of Task; 12 Appendix D: Documents Received by the Institute of Medicine from the National Institutes of Health; 13 Appendix E: Meeting Participants June, July, and August 1993; 14 Appendix F: Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial; 15 Appendix G: Women's Health Initiative Committees; 16 Appendix H: NIH-Sponsored Women's Health Studies; 17 Appendix I: NIH Cost and FTE Summary for Vanguard Clinical Centers; 18 Appendix J: NIH Power Calculations; 19 Appendix K: Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators; 20 Appendix L: Abbreviations and Acronyms; 21 Appendix M: Committee and Staff Biographies